Report Detail

Pharma & Healthcare Global Antibodies Market Insights, Forecast to 2025

  • RnM2716447
  • |
  • 14 July, 2020
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Antibodies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Antibodies market is segmented into
Monoclonal antibodies
Polyclonal antibodies
Antibody drug conjugates

Segment by Application, the Antibodies market is segmented into
Hospitals
Long-term care facilities
Research institutes

Regional and Country-level Analysis
The Antibodies market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antibodies market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antibodies Market Share Analysis
Antibodies market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antibodies business, the date to enter into the Antibodies market, Antibodies product introduction, recent developments, etc.

The major vendors covered:
Novartis
F. Hoffmann-La Roche
Johnson & Johnson Services
Amgen
Bristol-Myers Squibb
AbbVie
Eli Lilly
...


1 Study Coverage

  • 1.1 Antibodies Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Antibodies Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Antibodies Market Size Growth Rate by Type
    • 1.4.2 Monoclonal antibodies
    • 1.4.3 Polyclonal antibodies
    • 1.4.4 Antibody drug conjugates
  • 1.5 Market by Application
    • 1.5.1 Global Antibodies Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Long-term care facilities
    • 1.5.4 Research institutes
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Antibodies Market Size, Estimates and Forecasts
    • 2.1.1 Global Antibodies Revenue 2015-2026
    • 2.1.2 Global Antibodies Sales 2015-2026
  • 2.2 Global Antibodies, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Antibodies Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Antibodies Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Antibodies Competitor Landscape by Players

  • 3.1 Antibodies Sales by Manufacturers
    • 3.1.1 Antibodies Sales by Manufacturers (2015-2020)
    • 3.1.2 Antibodies Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Antibodies Revenue by Manufacturers
    • 3.2.1 Antibodies Revenue by Manufacturers (2015-2020)
    • 3.2.2 Antibodies Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Antibodies Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Antibodies Revenue in 2019
    • 3.2.5 Global Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Antibodies Price by Manufacturers
  • 3.4 Antibodies Manufacturing Base Distribution, Product Types
    • 3.4.1 Antibodies Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Antibodies Product Type
    • 3.4.3 Date of International Manufacturers Enter into Antibodies Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Antibodies Market Size by Type (2015-2020)
    • 4.1.1 Global Antibodies Sales by Type (2015-2020)
    • 4.1.2 Global Antibodies Revenue by Type (2015-2020)
    • 4.1.3 Antibodies Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Antibodies Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Antibodies Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Antibodies Revenue Forecast by Type (2021-2026)
    • 4.2.3 Antibodies Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Antibodies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Antibodies Market Size by Application (2015-2020)
    • 5.1.1 Global Antibodies Sales by Application (2015-2020)
    • 5.1.2 Global Antibodies Revenue by Application (2015-2020)
    • 5.1.3 Antibodies Price by Application (2015-2020)
  • 5.2 Antibodies Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Antibodies Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Antibodies Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Antibodies Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Antibodies by Country
    • 6.1.1 North America Antibodies Sales by Country
    • 6.1.2 North America Antibodies Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Antibodies Market Facts & Figures by Type
  • 6.3 North America Antibodies Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Antibodies by Country
    • 7.1.1 Europe Antibodies Sales by Country
    • 7.1.2 Europe Antibodies Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Antibodies Market Facts & Figures by Type
  • 7.3 Europe Antibodies Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Antibodies by Region
    • 8.1.1 Asia Pacific Antibodies Sales by Region
    • 8.1.2 Asia Pacific Antibodies Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Antibodies Market Facts & Figures by Type
  • 8.3 Asia Pacific Antibodies Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Antibodies by Country
    • 9.1.1 Latin America Antibodies Sales by Country
    • 9.1.2 Latin America Antibodies Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Antibodies Market Facts & Figures by Type
  • 9.3 Central & South America Antibodies Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Antibodies by Country
    • 10.1.1 Middle East and Africa Antibodies Sales by Country
    • 10.1.2 Middle East and Africa Antibodies Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Antibodies Market Facts & Figures by Type
  • 10.3 Middle East and Africa Antibodies Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Description and Business Overview
    • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis Antibodies Products Offered
    • 11.1.5 Novartis Related Developments
  • 11.2 F. Hoffmann-La Roche
    • 11.2.1 F. Hoffmann-La Roche Corporation Information
    • 11.2.2 F. Hoffmann-La Roche Description and Business Overview
    • 11.2.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 F. Hoffmann-La Roche Antibodies Products Offered
    • 11.2.5 F. Hoffmann-La Roche Related Developments
  • 11.3 Johnson & Johnson Services
    • 11.3.1 Johnson & Johnson Services Corporation Information
    • 11.3.2 Johnson & Johnson Services Description and Business Overview
    • 11.3.3 Johnson & Johnson Services Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Johnson & Johnson Services Antibodies Products Offered
    • 11.3.5 Johnson & Johnson Services Related Developments
  • 11.4 Amgen
    • 11.4.1 Amgen Corporation Information
    • 11.4.2 Amgen Description and Business Overview
    • 11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Amgen Antibodies Products Offered
    • 11.4.5 Amgen Related Developments
  • 11.5 Bristol-Myers Squibb
    • 11.5.1 Bristol-Myers Squibb Corporation Information
    • 11.5.2 Bristol-Myers Squibb Description and Business Overview
    • 11.5.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Bristol-Myers Squibb Antibodies Products Offered
    • 11.5.5 Bristol-Myers Squibb Related Developments
  • 11.6 AbbVie
    • 11.6.1 AbbVie Corporation Information
    • 11.6.2 AbbVie Description and Business Overview
    • 11.6.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 AbbVie Antibodies Products Offered
    • 11.6.5 AbbVie Related Developments
  • 11.7 Eli Lilly
    • 11.7.1 Eli Lilly Corporation Information
    • 11.7.2 Eli Lilly Description and Business Overview
    • 11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Eli Lilly Antibodies Products Offered
    • 11.7.5 Eli Lilly Related Developments
  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Description and Business Overview
    • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis Antibodies Products Offered
    • 11.1.5 Novartis Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Antibodies Market Estimates and Projections by Region
    • 12.1.1 Global Antibodies Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Antibodies Revenue Forecast by Regions 2021-2026
  • 12.2 North America Antibodies Market Size Forecast (2021-2026)
    • 12.2.1 North America: Antibodies Sales Forecast (2021-2026)
    • 12.2.2 North America: Antibodies Revenue Forecast (2021-2026)
    • 12.2.3 North America: Antibodies Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Antibodies Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Antibodies Sales Forecast (2021-2026)
    • 12.3.2 Europe: Antibodies Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Antibodies Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Antibodies Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Antibodies Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Antibodies Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Antibodies Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Antibodies Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Antibodies Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Antibodies Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Antibodies Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Antibodies Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Antibodies Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Antibodies Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Antibodies Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Antibodies Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Antibodies Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Antibodies . Industry analysis & Market Report on Antibodies is a syndicated market report, published as Global Antibodies Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,116.10
    4,674.15
    6,232.20
    3,623.10
    5,434.65
    7,246.20
    607,542.00
    911,313.00
    1,215,084.00
    325,806.00
    488,709.00
    651,612.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report